Geron (GERN) Metrics: History & Chart

Geron Corporation(GERN)

Biotechnology · Foster City, CA

$1.20-0.01 (-0.83%)

Delayed quote: Oct 6, 2026, 10:10 AM EDT

About Geron Corporation

Geron Corporation is an advanced-stage biopharmaceutical company dedicated to the creation and market introduction of treatments for myeloid blood cancers. Its primary drug candidate, imetelstat, is a telomerase inhibitor currently undergoing Phase 3 clinical evaluation. This therapy aims to suppress the unchecked proliferation of cancerous stem and progenitor cells characteristic of myeloid hematologic malignancies. Imetelstat is being developed to address low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. Established in 1990, Geron's corporate headquarters are located in Foster City, California.

Foster City, CA

258 employees

www.geron.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Harout Semerjian

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-3.20%
30D Total Return	-22.93%
YTD Total Return	-8.33%
1Y Total Return	-10.37%
3Y Total Return	-34.59%
5Y Total Return	-9.01%
10Y Total Return	-47.16%
15Y Total Return	-37.26%
20Y Total Return	-79.55%

2026	-8.33%
2025	-62.71%
2024	+67.77%
2023	-12.81%
2022	+98.36%
2021	-23.27%
2020

CAGR TTM	-10.32%
CAGR 3Y	-13.19%
CAGR 5Y	-1.87%
CAGR 10Y	-6.18%
CAGR 15Y	-3.06%
CAGR 20Y	-7.63%

PE Ratio	274.24
PE Ratio Avg TTM	973.22
PE Ratio Avg 3Y	973.22
Current VS TTM Avg	-71.82%
Current VS 3Y Avg	-71.82%
Current VS 5Y Avg	-71.82%

All Metrics

GERN Valuation Metrics

GERN Stock Price Metrics

GERN Dividend Metrics

GERN Growth Rate Metrics

GERN Discounted Cash Flow Metrics

GERN Returns By Period

GERN Yearly Returns

GERN Average Annual Returns By Period (CAGR)

GERN Revenue Metrics

GERN PE Ratio Metrics

GERN PS Ratio Metrics

GERN PB Ratio Metrics

GERN Price to Free Cash Flow Ratio Metrics

GERN Debt to Equity Ratio Metrics

GERN PEG Ratio Metrics

GERN FCF Yield

GERN Earnings Yield

GERN EBITDA Yield

GERN OCF Yield

GERN EV/EBIT Ratio Metrics

GERN EV/EBITDA Ratio Metrics

GERN EV/Assets Ratio Metrics

GERN EV/Sales Ratio Metrics

GERN Current Ratio Metrics

GERN Quick Ratio Metrics

GERN ROIC Metrics

GERN Return on Assets Metrics

GERN Return on Equity Metrics

GERN Net Profit Margin Metrics

GERN Gross Profit Margin Metrics

GERN Tax Rate Metrics

PS Ratio	3.97
PS Ratio Avg TTM	4.95
PS Ratio Avg 3Y	1330.17
Current VS TTM Avg	-19.81%
Current VS 3Y Avg	-99.70%
Current VS 5Y Avg	-99.67%

PB Ratio	3.71
PB Ratio Avg TTM	3.99
PB Ratio Avg 3Y	5.25
Current VS TTM Avg	-7.05%
Current VS 3Y Avg	-29.33%
Current VS 5Y Avg	-32.83%

PFCF Ratio	47.32
PFCF Ratio Avg TTM	60.32
PFCF Ratio Avg 3Y	60.32
Current VS TTM Avg	-21.55%
Current VS 3Y Avg	-21.55%
Current VS 5Y Avg	-21.55%

Debt/Equity Ratio	0.56
Debt/Equity Ratio Avg TTM	0.75
Debt/Equity Ratio Avg 3Y	0.36
Current VS TTM Avg	-25.13%
Current VS 3Y Avg	+54.95%
Current VS 5Y Avg	+46.86%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	2.11%
FCF Yield Avg TTM	1.71%
FCF Yield Avg 3Y	1.71%
Current VS TTM Avg	+23.59%
Current VS 3Y Avg	+23.59%
Current VS 5Y Avg	+23.59%

Earnings Yield	0.36%
Earnings Yield Avg TTM	0.17%
Earnings Yield Avg 3Y	0.17%
Current VS TTM Avg	+106.97%
Current VS 3Y Avg	+106.97%
Current VS 5Y Avg	+106.97%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	720.59
Ev/Ebit Ratio Avg TTM	957.13
Ev/Ebit Ratio Avg 3Y	957.13
Current VS TTM Avg	-24.71%
Current VS 3Y Avg	-24.71%
Current VS 5Y Avg	-24.71%

Ev/Ebitda Ratio	602.56
Ev/Ebitda Ratio Avg TTM	800.36
Ev/Ebitda Ratio Avg 3Y	800.36
Current VS TTM Avg	-24.71%
Current VS 3Y Avg	-24.71%
Current VS 5Y Avg	-24.71%

Ev/Assets Ratio	1.68
Ev/Assets Ratio Avg TTM	1.89
Ev/Assets Ratio Avg 3Y	3.13
Current VS TTM Avg	-11.15%
Current VS 3Y Avg	-46.38%
Current VS 5Y Avg	-47.69%

Ev/Sales Ratio	4.26
Ev/Sales Ratio Avg TTM	5.53
Ev/Sales Ratio Avg 3Y	1338.31
Current VS TTM Avg	-22.98%
Current VS 3Y Avg	-99.68%
Current VS 5Y Avg	-99.65%

Current Ratio	6.92
Current Ratio Avg TTM	6.44
Current Ratio Avg 3Y	5.22
Current VS TTM Avg	+7.46%
Current VS 3Y Avg	+32.46%
Current VS 5Y Avg	+38.88%

Quick Ratio	5.16
Quick Ratio Avg TTM	5.65
Quick Ratio Avg 3Y	4.80
Current VS TTM Avg	-8.73%
Current VS 3Y Avg	+7.35%
Current VS 5Y Avg	+14.18%

ROIC	(8.34%)
ROIC Avg 3Y	(33.78%)
ROIC Avg 5Y	(45.62%)
Current VS 3Y Avg	+75.32%
Current VS 5Y Avg	+81.72%
Current VS 10Y Avg	+76.48%

ROA	(13.47%)
ROA Avg TTM	(3.11%)
ROA Avg 3Y	(7.05%)
Current VS TTM Avg	-333.07%
Current VS 3Y Avg	-91.03%
Current VS 5Y Avg	-37.87%

ROE	(31.97%)
ROE Avg TTM	(33.28%)
ROE Avg 3Y	(51.62%)
Current VS TTM Avg	+3.93%
Current VS 3Y Avg	+38.06%
Current VS 5Y Avg	+43.56%

Net Profit Margin	(34.17%)
Net Profit Margin Avg TTM	(34.66%)
Net Profit Margin Avg 3Y	(4868.24%)
Current VS TTM Avg	+1.43%
Current VS 3Y Avg	+99.30%
Current VS 5Y Avg	+99.73%

Gross Profit Margin	97.42%
Gross Pft Margin Avg TTM	85.74%
Gross Pft Margin Avg 3Y	98.49%
Current VS TTM Avg	+13.62%
Current VS 3Y Avg	-1.08%
Current VS 5Y Avg	+327.06%

Tax Rate	0.08%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	+100.00%